Generic drugs the pay-for-delay problem /
Сохранить в:
Соавтор: | ebrary, Inc |
---|---|
Другие авторы: | Curtin, Christina M. |
Формат: | Электронный ресурс eКнига |
Язык: | английский |
Опубликовано: |
New York :
Nova Biomedical/Nova Science Publishers,
c2011.
|
Серии: | Public health in the 21st century series.
|
Предметы: | |
Online-ссылка: | An electronic book accessible through the World Wide Web; click to view |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Схожие документы
Pharmaceutical pricing policies in a global market
Опубликовано: (2008)
Опубликовано: (2008)
Les prix des medicaments sur un marche global politiques et enjeux.
Опубликовано: (2008)
Опубликовано: (2008)
Generic drugs needs and issues /
Опубликовано: (2009)
Опубликовано: (2009)
The competitive status of the U.S. pharmaceutical industry the influences of technology in determining international industrial competitive advantage /
Опубликовано: (1983)
Опубликовано: (1983)
The $800 million pill the truth behind the cost of new drugs /
по: Goozner, Merrill, 1950-
Опубликовано: (2004)
по: Goozner, Merrill, 1950-
Опубликовано: (2004)
Driving down the cost of drugs : battling big pharma in the statehouse /
по: Castellblanch, Ram�on, 1948-
Опубликовано: (2012)
по: Castellblanch, Ram�on, 1948-
Опубликовано: (2012)
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
по: Osmane, Malik
Опубликовано: (2014)
по: Osmane, Malik
Опубликовано: (2014)
Pharmaceutical economics and policy
по: Schweitzer, Stuart O.
Опубликовано: (2007)
по: Schweitzer, Stuart O.
Опубликовано: (2007)
Marketing Strategies Adopted by Generic and Original Drugs Manufacturing Companies in An Effort to Attain Strategic Competitiveness: A Study of Mombasa
по: Mueni, Matingi Ireen
Опубликовано: (2024)
по: Mueni, Matingi Ireen
Опубликовано: (2024)
The WetFeet insider guide to the top 20 biotechnology and pharmaceutical firms /
Опубликовано: (2003)
Опубликовано: (2003)
Profits before people? ethical standards and the marketing of prescription drugs /
по: Weber, Leonard J., 1942-
Опубликовано: (2006)
по: Weber, Leonard J., 1942-
Опубликовано: (2006)
CAPA for the FDA-regulated industry /
по: Rodríguez Pérez, José, 1961-
Опубликовано: (2010)
по: Rodríguez Pérez, José, 1961-
Опубликовано: (2010)
The risks of prescription drugs
Опубликовано: (2010)
Опубликовано: (2010)
ADME-enabling technologies for drug design and development
Опубликовано: (2012)
Опубликовано: (2012)
Drug discovery and design medical aspects /
Опубликовано: (2002)
Опубликовано: (2002)
Drugs : from discovery to approval /
по: Ng, Rick
Опубликовано: (2015)
по: Ng, Rick
Опубликовано: (2015)
Drug discovery practices, processes, and perspectives /
Опубликовано: (2013)
Опубликовано: (2013)
Modern drug synthesis
Опубликовано: (2010)
Опубликовано: (2010)
The art of drug synthesis
Опубликовано: (2007)
Опубликовано: (2007)
Chemical drug design /
Опубликовано: (2016)
Опубликовано: (2016)
Successful drug discovery.
Опубликовано: (2015)
Опубликовано: (2015)
Towards drugs of the future key issues in lead finding and lead optimization /
Опубликовано: (2008)
Опубликовано: (2008)
Drug repositioning bringing new life to shelved assets and existing drugs /
Опубликовано: (2012)
Опубликовано: (2012)
Frontiers in drug design and discovery.
Опубликовано: (2010)
Опубликовано: (2010)
Drug-like properties concepts, structure design and methods : from ADME to toxicity optimization /
по: Kerns, Edward Harvel
Опубликовано: (2008)
по: Kerns, Edward Harvel
Опубликовано: (2008)
Pharmaceutical blending and mixing /
Опубликовано: (2015)
Опубликовано: (2015)
Pharmaceutical industry innovation and developments /
Опубликовано: (2011)
Опубликовано: (2011)
Drug delivery strategies for poorly water-soluble drugs
Опубликовано: (2012)
Опубликовано: (2012)
Drug delivery principles and applications /
по: Wang, Binghe
Опубликовано: (2005)
по: Wang, Binghe
Опубликовано: (2005)
Drug delivery : principles and applications /
Опубликовано: (2016)
Опубликовано: (2016)
The agile approach to adaptive research optimizing efficiency in clinical development /
по: Rosenberg, Michael J.
Опубликовано: (2010)
по: Rosenberg, Michael J.
Опубликовано: (2010)
Therapeutic targets modulation, inhibition, and activation /
Опубликовано: (2012)
Опубликовано: (2012)
Manufacturing of pharmaceutical proteins : from technology to economy /
по: Behme, Stefan
Опубликовано: (2015)
по: Behme, Stefan
Опубликовано: (2015)
Case studies in modern drug discovery and development
Опубликовано: (2012)
Опубликовано: (2012)
Advanced drug delivery /
Опубликовано: (2013)
Опубликовано: (2013)
How to develop and implement a national drug policy
Опубликовано: (2001)
Опубликовано: (2001)
Predictive approaches in drug discovery and development biomarkers and in vitro/in vivo correlations /
Опубликовано: (2012)
Опубликовано: (2012)
Effective drug regulation a multicountry study /
по: Ratanawijitrasin, Sauwakon
Опубликовано: (2002)
по: Ratanawijitrasin, Sauwakon
Опубликовано: (2002)
The future of drug safety promoting and protecting the health of the public /
Опубликовано: (2007)
Опубликовано: (2007)
Outsourcing clinical development strategies for working with CROs and other partners /
Опубликовано: (2006)
Опубликовано: (2006)
Схожие документы
-
Pharmaceutical pricing policies in a global market
Опубликовано: (2008) -
Les prix des medicaments sur un marche global politiques et enjeux.
Опубликовано: (2008) -
Generic drugs needs and issues /
Опубликовано: (2009) -
The competitive status of the U.S. pharmaceutical industry the influences of technology in determining international industrial competitive advantage /
Опубликовано: (1983) -
The $800 million pill the truth behind the cost of new drugs /
по: Goozner, Merrill, 1950-
Опубликовано: (2004)